Pasireotide Extended-Release Injection and Prochieve
Determining the interaction of Pasireotide Extended-Release Injection and Prochieve and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: progesterone
Brand name: Crinone, Endometrin, FIRST-Progesterone VGS 200, Prochieve, First Progesterone MC10, Menopause Formula Progesterone, Prometrium
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Prochieve (Progesterone Vaginal 4% Gel)
- Pasireotide Extended-Release Injection-Prochieve (Progesterone Vaginal 8% Gel)
- Pasireotide Extended-Release Injection-Prochlorperazine
- Pasireotide Extended-Release Injection-Prochlorperazine Edisylate
- Pasireotide Extended-Release Injection-Prochlorperazine Injection
- Pasireotide Extended-Release Injection-Prochlorperazine Maleate
- Prochieve-Pasireotide Injection
- Prochieve-Pasireotide Subcutaneous
- Prochieve-Patanase
- Prochieve-Patiromer
- Prochieve-Patiromer Sorbitex Calcium
- Prochieve-Pavacot